ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,982.30
0.14%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT
  6. Gilead Sciences Inc (GILD)

  7. Gilead Sciences Inc (GILD) News

Gilead Sciences (GILD)

Gilead Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:BIT:GILD
DateTimeSourceHeadlineSymbolCompany
21/08/201221:03Dow Jones NewsGilead Stops Development of Lung Drug Cicletanine After Missing Study GoalLSE:GILD
16/10/200919:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesLSE:GILDGilead Sciences Inc.
15/08/200900:11Dow Jones NewsGilead: US Requests Documents About Angina DrugLSE:GILDGilead Sciences Inc.
30/07/200922:00Dow Jones NewsMARKET SNAPSHOT: As Earnings Doubts Fade, Stocks Set Sights On GDPLSE:GILDGilead Sciences Inc.
21/07/200923:43Dow Jones NewsUPDATE: Gilead Sciences 2Q Profit Up 31% On HIV Drug SalesLSE:GILDGilead Sciences Inc.
21/07/200923:16Dow Jones NewsGilead Projects 2009 Net Product Revenue $6.1 Billion-$6.2 BillionLSE:GILDGilead Sciences Inc.
21/07/200921:56Dow Jones NewsGilead Sciences 2Q Profit Up 31% On Higher HIV Product SalesLSE:GILDGilead Sciences Inc.
14/05/200922:26Dow Jones NewsGilead Sciences Files Patent Infringements Suit Against TevaLSE:GILDGilead Sciences Inc.
05/05/200912:17Dow Jones NewsCipla Gets Tentative FDA OK For Tenofovir Disoproxil FumarateLSE:GILDGilead Sciences Inc.
27/04/200917:59Dow Jones NewsFOCUS: Drug Companies Prepare For Possible Flu PandemicLSE:GILDGilead Sciences Inc.
27/04/200915:30Dow Jones NewsGilead, Glaxo, Roche Gain On Swine Flu FearsLSE:GILDGilead Sciences Inc.
27/04/200914:51Dow Jones NewsUPDATE: Drug Companies Get Ready For Possible Flu PandemicLSE:GILDGilead Sciences Inc.
24/04/200918:59Dow Jones NewsAmgen Investors Bet That Worst Is Over After Dismal 1QLSE:GILDGilead Sciences Inc.
21/04/200923:57Dow Jones NewsUPDATE: Gilead Shares Gain After Hours; Beat 1Q ForecastsLSE:GILDGilead Sciences Inc.
21/04/200922:55Dow Jones NewsGilead Sciences 1Q Net Up 20% On Strong Growth In Drug SalesLSE:GILDGilead Sciences Inc.
20/04/200915:45Dow Jones NewsUS Supreme Court Won't Hear Tuna Fish-Mercury CaseLSE:GILDGilead Sciences Inc.
16/04/200921:21Dow Jones NewsDEALWATCH: Dull Pharma JV May Become Alluring Spin-Off, SaleLSE:GILDGilead Sciences Inc.
13/04/200918:04Dow Jones NewsEARNINGS PREVIEW: Biotechs Hit By Credit Woes; Deals SeenLSE:GILDGilead Sciences Inc.
06/04/200923:08Dow Jones NewsGilead Reviews Teva's Generic Application, May File SuitLSE:GILDGilead Sciences Inc.
31/03/200911:31Dow Jones NewsAurobindo Gets Tentative US OK For Combination TabletLSE:GILDGilead Sciences Inc.
31/03/200906:58Dow Jones NewsMatrix Laboratories Gets Tentative FDA OK For Generic TruvadaLSE:GILDGilead Sciences Inc.
16/03/200919:01Dow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsLSE:GILDGilead Sciences Inc.
16/03/200918:45Dow Jones NewsGilead Sciences Backs 2009 Sales View $5.9 Billion-$6 BillionLSE:GILDGilead Sciences Inc.
16/03/200916:18Dow Jones NewsUnited Therapeutics Shares Fall On Delay To Hypertension DrugLSE:GILDGilead Sciences Inc.
16/03/200915:10Dow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionLSE:GILDGilead Sciences Inc.
16/03/200909:12Dow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsLSE:GILDGilead Sciences Inc.
16/03/200907:08Dow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsLSE:GILDGilead Sciences Inc.
13/03/200912:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsLSE:GILDGilead Sciences Inc.
12/03/200920:42Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsLSE:GILDGilead Sciences Inc.
12/03/200914:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionLSE:GILDGilead Sciences Inc.
 Showing the most relevant articles for your search:BIT:GILD

Your Recent History

LSE
CHLL
Chill Brands
LSE
AGL
Angle
LSE
SRSP
Sirius Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
SCE
Surface Transforms
LSE
SCLP
Scancell
LSE
SBTX
Skinbiotherapeutics
LSE
POS
Plexus
LSE
AAU
Ariana Resources
LSE
INSG
Insig Ai
LSE
HUM
Hummingbird Resources
LSE
LLOY
Lloyds Banking
LSE
BIRD
Blackbird
LSE
ALBA
Alba Mineral Resources
LSE
APTA
Aptamer
LSE
BT.A
Bt
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved